Figure 4.
Temsirolimus and recombinant AMH in vivo primordial follicle counting. Ovaries from 8-week-old mice that were removed 21 days after a single dose of Cyclophosphamide (Cy, 150 mg/kg) or the equivalent volume of PBS with or without cotreatment with Temsirolimus (Tem) and/or recombinant anti-Müllerian hormone (AMH) and were stained with hematoxylin and eosin for follicle count: primordial follicles were counted 21 days after Cy treatment. Fourteen to 16 ovaries were counted for follicles per group, ***P < 0.001. Data were expressed as the mean ± SEM. Statistical analyses were performed by the mixed procedure followed by Tukey’s multiple comparison test.

Temsirolimus and recombinant AMH in vivo primordial follicle counting. Ovaries from 8-week-old mice that were removed 21 days after a single dose of Cyclophosphamide (Cy, 150 mg/kg) or the equivalent volume of PBS with or without cotreatment with Temsirolimus (Tem) and/or recombinant anti-Müllerian hormone (AMH) and were stained with hematoxylin and eosin for follicle count: primordial follicles were counted 21 days after Cy treatment. Fourteen to 16 ovaries were counted for follicles per group, ***P < 0.001. Data were expressed as the mean ± SEM. Statistical analyses were performed by the mixed procedure followed by Tukey’s multiple comparison test.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close